Plasma insulin-like growth factor binding protein-3 proteolysis is increased in primary breast cancer

por Helle, S I, Geisler, S, Aas, T, Paulsen, T, Holly, J M P, Lønning, P E
Publicado 2001

Inhibition of FASN and ERα signalling during hyperglycaemia-induced matrix-specific EMT promotes breast cancer cell invasion via a caveolin-1-dependent mechanism

por Zielinska, H.A., Holly, J.M.P., Bahl, A., Perks, C.M.
Publicado 2018

Activation of integrin and ceramide signalling pathways can inhibit the mitogenic effect of insulin-like growth factor I (IGF-I) in human breast cancer cell lines

por Perks, C M, Gill, Z P, Newcomb, P V, Holly, J M P
Publicado 1999

Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer

por Helle, S I, Geisler, J, Anker, G B, Leirvaag, B, Holly, J M P, Lønning, P E
Publicado 2001

Hyperglycaemia-induced resistance to Docetaxel is negated by metformin: a role for IGFBP-2

por Biernacka, K M, Persad, R A, Bahl, A, Gillatt, D, Holly, J M P, Perks, C M
Publicado 2016

Prolactin acts as a potent survival factor for human breast cancer cell lines

por Perks, C M, Keith, A J, Goodhew, K L, Savage, P B, Winters, Z E, Holly, J M P
Publicado 2004

Differential interactions between IGFBP-3 and transforming growth factor-beta (TGF-β) in normal vs cancerous breast epithelial cells

por McCaig, C, Fowler, C A, Laurence, N J, Lai, T, Savage, P B, Holly, J M P, Perks, C M
Publicado 2002

Insulin-like growth factor-binding protein-2 promotes prostate cancer cell growth via IGF-dependent or -independent mechanisms and reduces the efficacy of docetaxel

por Uzoh, C C, Holly, J M P, Biernacka, K M, Persad, R A, Bahl, A, Gillatt, D, Perks, C M
Publicado 2011

Microencapsulated octreotide pamoate in advanced gastrointestinal and pancreatic cancer: a phase I study.

por Helle, S. I., Geisler, J., Poulsen, J. P., Hestdal, K., Meadows, K., Collins, W., Tveit, K. M., Holly, J. M., Lønning, P. E.
Publicado 1998

A prospective study of serum insulin-like growth factor-I (IGF-I), IGF-II, IGF-binding protein-3 and breast cancer risk

por Allen, N E, Roddam, A W, Allen, D S, Fentiman, I S, dos Santos Silva, I, Peto, J, Holly, J M P, Key, T J
Publicado 2005

Are diet–prostate cancer associations mediated by the IGF axis? A cross-sectional analysis of diet, IGF-I and IGFBP-3 in healthy middle-aged men

por Gunnell, D, Oliver, S E, Peters, T J, Donovan, J L, Persad, R, Maynard, M, Gillatt, D, Pearce, A, Hamdy, F C, Neal, D E, Holly, J M P
Publicado 2003